Profil
Cecilia Ganslandt worked as Head-Section & Medical Science at LEO Pharma.
A from 2011 to 2012.
She was the Medical Manager-Dermatology at AbbVie A from 2013 to 2014.
From 2014 to 2016, she served as the Chief Medical Officer at Serendex Pharmaceuticals A.
She then worked as Vice President & Head-Clinical Development at Savara, Inc. from 2016 to 2021.
Ganslandt holds a doctorate from the University of Lund and a graduate degree from the University of Surrey.
Anciens postes connus de Cecilia Ganslandt
| Sociétés | Poste | Fin |
|---|---|---|
| SAVARA INC. | Directeur Technique/Scientifique/R&D | 01/03/2021 |
| SERENDEX PHARMACEUTICALS A/S | Directeur Technique/Scientifique/R&D | 01/07/2016 |
AbbVie A/S (Denmark)
 AbbVie A/S (Denmark) Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie A/S is a Danish biopharmaceutical company that develops and manufactures medicines. The company is based in Copenhagen, Denmark. | Corporate Officer/Principal | 01/04/2014 |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | 01/10/2012 |
Formation de Cecilia Ganslandt
| University of Lund | Doctorate Degree |
| University of Surrey | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SAVARA INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Serendex Pharmaceuticals A/S
 Serendex Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Serendex Pharmaceuticals A/S engages in the research and development of pharmaceuticals for respiratory conditions. It develops drugs to treat respiratory conditions such as Pulmonary Alveolar Proteinosis, Bronchiectasis, Cystic Fibrosis related lung infections and Diffuse Alveolar Hemorrhage. The company was founded by Lars Heslet on October 31, 2008 and is headquartered in Horsholm, Denmark. | Health Technology |
AbbVie A/S (Denmark)
AbbVie A/S (Denmark) Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie A/S is a Danish biopharmaceutical company that develops and manufactures medicines. The company is based in Copenhagen, Denmark. | Health Technology |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
